Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study
- 24 June 2000
- Vol. 320 (7251) , 1706-1707
- https://doi.org/10.1136/bmj.320.7251.1706
Abstract
We conducted a population based, prospective, four year follow up study of men aged 54 or 60 in the Kuopio ischaemic heart disease risk factor study, a population study in eastern Finland.4 Of 633 eligible men, 555 (88%) participated in the four year follow up. Of these, 508 were not diabetic (fasting blood glucose concentration ≥6.7 mmol/l and no treatment for diabetes)at baseline. A participant was defined diabetic at the end of the follow up if he had a fasting blood glucose concentration≥6.7 mmol/l, a blood glucose concentration of ≥10.0 mmol/l two hours after a glucose load, or clinical diagnosis of diabetes requiring dietary, oral, or insulin treatment.Keywords
This publication has 5 references indexed in Scilit:
- Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr MutationCirculation, 1999
- Global prevalence of putative haemochromatosis mutations.Journal of Medical Genetics, 1997
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- Diabetes and haemochromatosis: current concepts, management and prevention.1995
- Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in menBMJ, 1995